The Biosimulation Market is becoming an increasingly important component of modern pharmaceutical research as companies seek computational tools that can improve development efficiency. The market is projected to rise from USD 2.64 billion in 2025 to USD 6.8 billion by 2035, reflecting a 9.9% CAGR over the forecast period. Software solutions are central to this transformation because they...